White Michael, Fong Yuman, Melstrom Laleh
Cancer Treat Res. 2016;168:221-31. doi: 10.1007/978-3-319-34244-3_11.
Operations on the liver have been undertaken for centuries for numerous indications including trauma, infections, and even for malignancy, but it was not until the past few decades that rates dramatically increased. This expanse in liver operations is due to a multitude of factors, including broader indications as well as improved safety. Our understanding of metastatic disease to the liver, especially colorectal cancer metastases, has vastly amplified the number of patients who would be candidates for hepatic resections and liver-directed therapies. We will focus our discussion here on planned minimally invasive operations for benign and malignant tumors as the majority of the literature relates to this setting.
几个世纪以来,人们针对包括创伤、感染甚至恶性肿瘤在内的多种适应症进行肝脏手术,但直到过去几十年,手术率才大幅上升。肝脏手术范围的扩大归因于多种因素,包括适应症的拓宽以及安全性的提高。我们对肝脏转移性疾病,尤其是结直肠癌转移的认识,极大地增加了适合肝切除和肝脏定向治疗的患者数量。我们将在此重点讨论针对良性和恶性肿瘤的计划性微创手术,因为大多数文献都涉及这种情况。